Pharminho: Pharma Regulatory
Drug approvals, data & experts
Free · In‑App Purchases · Designed for iPad. Not verified for macOS.
Pharminho is the fast, reliable way for Pharma professionals to check drug regulatory information for India — approval status, status dates, categories and more — across a repository of 15,000+ drugs.
Built for regulatory affairs, R&D and QA teams, Pharminho brings the regulatory intelligence you usually chase across scattered sources into one searchable app. Look up any drug, see where it stands with the authorities, follow the upcoming pipeline, read the latest Pharma news, and get custom answers from our consulting team — without leaving the app.
WHY PHARMINHO
• 15,000+ drugs with regulatory data at your fingertips
• Approval status, status date and category for every drug
• Upcoming drugs pipeline with regulatory details
• Latest CDSCO and Pharma regulatory news, updated regularly
• Expert consulting services for your specific queries
• Medical Devices, IVD & Non-Sterile Devices module
• Bookmarks and tracking to stay on top of what matters
DRUG REPOSITORY: Search 15,000+ drugs by name and open detailed regulatory profiles. Pro members unlock deeper insights — strengths & compositions, indications, official approval letters, approval pathway, applicant details and license checklists.
UPCOMING DRUGS: Track what's in the pipeline. Follow drugs under review, their current stage and applicant details so you can plan ahead.
SERVICES CATALOGUE:
Need a custom answer? Request services like global approval status (USFDA, EMA, MHRA, TGA), personalized regulatory assessments, custom approval pathways and market research reports — delivered by our team, typically in 2–3 working days.
MEDICAL DEVICES & DIAGNOSTICS:
A dedicated module for Medical Devices, In Vitro Diagnostics (IVD) and Non-Sterile Devices is on the way — bringing the same regulatory clarity to device professionals.
PHARMA BLOG: Stay current with regularly updated articles on approvals, enforcement actions and the regulatory changes shaping the industry.
PRO MEMBERSHIP:
Go Pro to unlock restricted regulatory insights and avail consulting services. Flexible plans from 1 month to 3 years, with bigger savings on longer plans. Manage your membership and in-app VCash wallet in one place, and track every service and transaction in a single view.
WHO IT'S FOR
Regulatory affairs professionals, dossier and submission planners, R&D and QA teams, and compliance specialists who need quick, dependable Pharma regulatory information.
Available in India (₹) and internationally ($).
DISCLAIMER
Pharminho is an independent, privately operated app. We are not affiliated with, endorsed by, or associated with CDSCO, DCGI, USFDA, EMA, or any other government body, regulatory authority, or official agency. Any references to such authorities are for informational purposes only.
While we strive to keep the information on Pharminho as accurate and up to date as possible, we make no representation or warranty of any kind regarding its completeness, accuracy, reliability, or timeliness. All information is provided "as is" for general reference only and should not be treated as legal, regulatory, or professional advice. Users are responsible for independently verifying any information before relying on it. To the fullest extent permitted by law, Pharminho and its operators accept no liability or accountability for any loss, damage, or consequence arising from the use of, or reliance on, any information available through the app.
Questions?
Reach us at pharminho@vaayath.com
Pharminho – Independent Pharmaceutical Regulatory Information Platform
Official Public Data Sources
CDSCO – https://cdsco.gov.in/
CDSCO Online – https://cdscoonline.gov.in/
FDA – https://www.fda.gov/
EMA – https://www.ema.europa.eu/
All information is sourced from publicly accessible official websites and organized for user convenience and research purposes.
Ratings & Reviews
- This app hasn’t received enough ratings or reviews to display an overview.
What's New
- Added the new **BCS Classification** drug list and detailed information.
- Explore BCS Class I, II, III & IV drug classifications.
- Fixed bugs and improved app stability.
- Improved overall performance and user experience.
The developer, Vaayath Infotech Private Limited, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Linked to You
The following data may be collected and linked to your identity:
- Purchases
- Contact Info
- Identifiers
- Sensitive Info
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- User Content
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Vaayath Infotech Private Limited
- Size
- 60.4 MB
- Category
- Business
- Compatibility
Requires iOS 15.0 or later.
- iPhone
Requires iOS 15.0 or later. - iPad
Requires iPadOS 15.0 or later. - iPod touch
Requires iOS 15.0 or later. - Mac
Requires macOS 12.0 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 1.0 or later.
- iPhone
- Languages
- English
- Age Rating
13+
- 13+
- Infrequent
Alcohol, Tobacco, Drug Use or References
- In-App Purchases
Yes
- Pro - 5 Years $749.99
- Pro - 3 Years $539.99
- Pro - 2 Years $389.99
- Pro - 1 Year $224.99
- Pro - 6 Months $127.99
- Pro - 3 Months $67.90
- Pro - 1 Month $25.00
- Copyright
- © 2026 Vaayath Infotech Private Limited